Alyeska Investment Group
DFTX

Alyeska Investment Group’s Definium Therapeutics DFTX Stock Holding History

Alyeska Investment Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-66,694
Closed -$379K – 625
2024
Q3 		$379K Buy
+66,694
New +$464K ﹤0.01% 494
2024
Q2 		– Hold
0
– – – 660
2024
Q1 		– Hold
0
– – – 594
2023
Q3 		– Sell
-796,962
Closed -$2.85M – 592
2023
Q2 		$2.85M Sell
796,962
-245,677
-24% -$847K 0.02% 383
2023
Q1 		$3.31M Sell
1,042,639
-57,361
-5% -$191K 0.03% 326
2022
Q4 		$2.42M Buy
1,100,000
+100,000
+10% +$278K 0.03% 306
2022
Q3 		$3.5M Buy
+1,000,000
New +$9.6M 0.04% 288

Other funds holding DFTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return